Loading...
NanoVibronix, Inc.
NAOV•NASDAQ
Healthcare
Medical - Devices
$0.93
$-0.24(-20.75%)
NanoVibronix, Inc. (NAOV) Financial Performance & Statements
Review NanoVibronix, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
12.05%
↑ 12.05%
Operating Income Growth
-4.25%
↓ 4.25%
Net Income Growth
0.16%
↑ 0.16%
Operating Cash Flow Growth
30.15%
↑ 30.15%
Operating Margin
-182.79%
↓ 182.79%
Gross Margin
45.57%
↑ 45.57%
Net Profit Margin
-210.82%
↓ 210.82%
ROE
-54.73%
↓ 54.73%
ROIC
-13.55%
↓ 13.55%
NanoVibronix, Inc. (NAOV) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for NanoVibronix, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $444000.00 | $376000.00 | $817000.00 | $921000.00 |
| Cost of Revenue | $161000.00 | $243000.00 | $389000.00 | $257000.00 |
| Gross Profit | $283000.00 | $133000.00 | $428000.00 | $664000.00 |
| Gross Profit Ratio | $0.64 | $0.35 | $0.52 | $0.72 |
| R&D Expenses | $352000.00 | $249000.00 | $187000.00 | $121000.00 |
| SG&A Expenses | $1.30M | $854000.00 | $915000.00 | $1.11M |
| Operating Expenses | $1.65M | $1.10M | $1.10M | $1.23M |
| Total Costs & Expenses | $1.81M | $1.35M | $1.49M | $1.49M |
| Interest Income | -$22000.00 | $8000.00 | $0.00 | $0.00 |
| Interest Expense | $34000.00 | $33000.00 | $0.00 | $13000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $1000.00 | $250.00 |
| EBITDA | -$1.39M | -$970000.00 | -$673000.00 | -$567750.00 |
| EBITDA Ratio | -$3.14 | -$2.58 | -$0.82 | -$0.62 |
| Operating Income | -$1.37M | -$970000.00 | -$674000.00 | -$568000.00 |
| Operating Income Ratio | -$3.09 | -$2.58 | -$0.82 | -$0.62 |
| Other Income/Expenses (Net) | -$56000.00 | -$25000.00 | -$10000.00 | -$13000.00 |
| Income Before Tax | -$1.43M | -$995000.00 | -$684000.00 | -$595000.00 |
| Income Before Tax Ratio | -$3.21 | -$2.65 | -$0.84 | -$0.65 |
| Income Tax Expense | $5000.00 | $3000.00 | $4000.00 | -$7000.00 |
| Net Income | -$1.43M | -$998000.00 | -$688000.00 | -$588000.00 |
| Net Income Ratio | -$3.22 | -$2.65 | -$0.84 | -$0.64 |
| EPS | -$4.51 | -$0.36 | -$0.25 | -$0.23 |
| Diluted EPS | -$4.51 | -$0.36 | -$0.25 | -$0.23 |
| Weighted Avg Shares Outstanding | $3.17M | $2.80M | $2.78M | $2.51M |
| Weighted Avg Shares Outstanding (Diluted) | $3.17M | $2.80M | $2.78M | $2.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan